Drug for epilepsy








Drug-Resistant Epilepsy NEJM

8/15/2014
04:22 | Author: Chloe Allen

Drug for epilepsy
Drug-Resistant Epilepsy NEJM

Review Article from The New England Journal of Medicine — Drug-Resistant Epilepsy.

Our apologies. An error occurred while setting your user cookie. Please set your browser to accept cookies to continue.

uses cookies to improve performance by remembering your session ID when you navigate from page to page. This cookie stores just a session ID; no other information is captured. Accepting the NEJM cookie is necessary to use the website.

Comments (0)



New cannabis-based epilepsy drug showing 39promise39 in clinical

6/14/2014
02:04 | Author: Allison King

Drug for epilepsy
New cannabis-based epilepsy drug showing 39promise39 in clinical

4 days ago A new cannabis-based drug for children with severe epilepsy is showing “promising” signs in clinical trials.

How mobile technology has changed the instant trading game.

Tuesday 14 October 2014.

£35000 - £45000 Per Annum Pensions Scheme After 6 Months: Clearwater People So.

Lines ruled at New York Fashion Week as highlighter stripes took centre stage. Emma McCarthy gets next season’s look now.

Maria Roberta Cilio, who is testing the drug at the Benioff Children’s Hospital in San Francisco, said studies on animals had showed cannabidiol works as an anticonvulsant.

Met Police confirm there was a 'minor disturbance' and that no-one was arrested.

Epidiolex is being tested on children with Dravet Syndrome and other forms of epilepsy that do not respond to existing drugs.

Out of 151 patients in safety testing for the drug, 26 experienced serious adverse effects and two died, although GW Pharmaceuticals said independent investigations found they were unrelated to the trial.

Please provide search keyword(s).

Sales of the tablet are set to fall again, say analysts.

Peter Biaksangzuala died from his injuries in hospital on Sunday.

When winter comes to Austria it is distinctly special and all embracing.

Comments (2)Read more

Brain stimulator reduces seizures in patients with drug-resistant

4/13/2014
12:06 | Author: Chloe Allen

Drug for epilepsy
Brain stimulator reduces seizures in patients with drug-resistant

In 2013, the Food and Drug Administration approved an implantable medical device to treat epilepsy. Now, doctors from the Rush Epilepsy.

From that trial, results showed that 29% of patients with an active device experienced a 50% reduction in total number of disabling seizures in the 3-month blinded period, compared with 27% for patients with the device turned off.

In their approval release, the Food and Drug Administration (FDA) explain that the RNS System is used alongside drugs in patients over the age of 18 with three or more "disabling seizures" each month and who have not responded to two or more medications for epilepsy.

: Medical News Today Not to be reproduced without permission.

Please see our privacy policy for more information.

Comments (3)Read more

A cannabis-based drug is showing 39promise39 in children with severe

2/12/2014
02:28 | Author: Jeremy Rodriguez

Drug for epilepsy
A cannabis-based drug is showing 39promise39 in children with severe

5 days ago Epidiolex, made from cannabis extract cannabidiol, has reduced seizure frequency by half in children with Dravet Syndrome.

“I believe that Epidiolex has the potential to be an important advance in treatment for these treatment-resistant children and will likely have a significant role as a future therapy," she added.

Apple boss Tim Cook says 2014 is 'one for the record books' as iPhone maker gears up for a strong Christmas shopping season.

The medicine, known as Epidiolex, has reduced seizure frequency by a half to three-quarters, on average, in a small group of children with a debilitating form of epilepsy known as Dravet Syndrome.

The world's first medically-approved 'cigarette'?

In Pharmaceuticals and Chemicals.

Bank of England Governor promises 'thorough, independent review' after Real Time Gross Settlement payment system, which processes £277bn a day, resumes operations after being down for 10 hours.

We name the sectors in the firing line if Ed Miliband wins the keys to Downing Street next May.

In Finance».

Comments (4)Read more